Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Vijayalakshmi Nandakumar to Enzyme-Linked Immunosorbent Assay

This is a "connection" page, showing publications Vijayalakshmi Nandakumar has written about Enzyme-Linked Immunosorbent Assay.

 
Connection Strength
 
 
 
1.874
 
  1. Saadalla A, Novis CL, Banerjee D, Martins T, Holloway B, Ann Aure M, Mahler M, Nandakumar V. Comparative assessment of the diagnostic performances of particle-based multianalyte technology and commercial ELISA for antiphospholipid autoantibody testing. Clin Chim Acta. 2024 Aug 15; 562:119849.
    View in: PubMed
    Score: 0.758
  2. Nandakumar V, Profaizer T, Lozier BK, Elgort MG, Larragoite ET, Williams ESCP, Solis-Leal A, Lopez JB, Berges BK, Planelles V, Rychert J, Slev PR, Delgado JC. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays. Arch Pathol Lab Med. 2021 10 01; 145(10):1212-1220.
    View in: PubMed
    Score: 0.626
  3. Profaizer T, Saadalla A, Nandakumar V. Validation for soluble C5b-9 detection and comparative analysis of three quantification methods. J Immunol Methods. 2025 Jun; 541:113882.
    View in: PubMed
    Score: 0.201
  4. Dadelahi A, Walker BS, Banerjee D, Mahler M, Saadalla A, Nandakumar V. Is the 99th Percentile Cutoff Still Relevant? A Single-Center Assessment of Different Thresholds for Diagnosing Antiphospholipid Syndrome. J Appl Lab Med. 2025 May 02; 10(3):605-618.
    View in: PubMed
    Score: 0.201
  5. Zhang XS, Bizzaro N, Tebo AE, Nandakumar V, Infantino M, Carbone T, Bossuyt X, Damoiseaux J. Discouraging Non-ELISA antiphospholipid antibody assays in antiphospholipid syndrome classification may hinder clinical research. Immunol Res. 2024 06; 72(3):361-363.
    View in: PubMed
    Score: 0.046
  6. Jaskowski TD, Nandakumar V, Novis CL, Palmer M, Tebo AE. Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis. Clin Chim Acta. 2023 Feb 01; 540:117219.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)